Besides GLP-1, DPP-4 also has other substrates and their elevation by DPP-4 inhibition can also contribute to a normalization of glycaemia in type 2 diabetes (“indirect target” or “off-target”) (10). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.